Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CEM Specialties Inc. (CEMSI) is a Canadian technology company specializing in continuous emissions monitoring systems (CEMS) and process analytics for industrial and environmental applications. While its core business involves the integration and maintenance of gas analysis equipment for sectors like power and mining, the company expanded into the healthcare and life sciences space with the development of BioCloud. BioCloud is an automated, real-time airborne pathogen detection system designed to identify the presence of SARS-CoV-2 and other viruses in indoor environments. CEMSI also provides analytical solutions for pharmaceutical manufacturing plants to ensure regulatory compliance and process efficiency. The company was acquired by Alliance Technical Group in June 2024.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CEM Specialties.